[Efficacy and Safety of Ixazomib Combined with Thalidomide and Dexamethasone in Treatment of Multiple Myeloma].

Ixazomib combined with thalidomide and dexamethasone is effective in the treatment of MM, with good short-term efficacy, survival and safety. However, its long-term efficacy needs further observation.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-10-01
DOI
https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.023
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Efficacy and Safety of Ixazomib Combined with Thalidomide and Dexamethasone in Treatment of Multiple Myeloma].

Hai‐Tao He, Jianhua Rao, Zhixiang Lu, Xiangmei Yao et al.
PubMed
Multiple Myeloma Research and Treatments
article

[Efficacy and Safety of Ixazomib Combined with Thalidomide and Dexamethasone in Treatment of Multiple Myeloma].

Hai‐Tao He, Jianhua Rao, Zhixiang Lu, Xiangmei Yao, Xiaoli Gao, Qi Wang
article en

Abstract

Ixazomib combined with thalidomide and dexamethasone is effective in the treatment of MM, with good short-term efficacy, survival and safety. However, its long-term efficacy needs further observation.

PubMedVol. 32(5)
First People's Hospital of Yunnan Province (CN), Second People's Hospital of Yunnan Province (CN)
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.